Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 5/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26981009 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL442243 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL2581397 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL28525744 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL28477983 | 1.00 | LMNA (0.52) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| Methylamine SCHEMBL9488577 | 0.96 | LMNA (0.49) | LMNAFAAHABCB1ZDHHC7ACE2 | |
| SCHEMBL28488646 | 0.92 | LMNA (0.46) | LMNAFAAHABCB1ZDHHC7CA1 | |
| SCHEMBL19899177 | 0.91 | FAAH (0.44) | LMNAFAAHMAPTPPARD | |
| SCHEMBL28404579 | 0.84 | LMNA (0.48) | LMNAFAAHZDHHC7CA1 | |
| SCHEMBL3179799 | 0.83 | ZDHHC7 (0.46) | LMNAFAAHABCB1ZDHHC7ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113195060-B | External preparation | 花王株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-116685338-A | Compositions and methods for improving skin health and for treating and preventing diseases, disorders and conditions associated with fungi and other pathogenic microorganisms | 德慕拜昂生物科技公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-114401707-A | High oil content gel compositions and methods of making and using the same | 巴斯夫欧洲公司 | 2022-04-26 | — | — | CN | disclosed |
| EP-3808359-A1 | COMBINATION OF NATURAL ACTIVE INGREDIENTS PROMOTING APOPTOSIS IN DAMAGED OR SUFFERING SKIN TISSUES | Valetudo S.r.l. Con Unico Socio (IT) | 2021-04-21 | — | — | EP | disclosed |
| CN-112351764-A | Compositions with increased tonal stability | 雅芳产品公司 | 2021-02-09 | — | — | CN | disclosed |
| US-20150283048-A1 | TEXTILE-SPARING ANTIPERSPIRANT SPRAYS WITH HYDROXYCARBOXYLIC ACIDS | HENKEL AG & CO. KGAA (DE) | 2015-10-08 | — | — | US | disclosed |
| US-8409609-B2 | Percutaneous absorption-type pharmaceutical preparation | NITTO DENKO CORPORATION (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8287846-B2 | Cosmetic or dermatological preparations comprising N-acetylcysteine | ZAMBON S.P.A. (IT) | 2012-10-16 | — | — | US | disclosed |
| EP-1716850-B1 | Transdermal plaster | NITTO DENKO CORP (JP) | 2012-05-23 | — | — | EP | disclosed |
| EP-2046277-B1 | COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING N-ACETYLCYSTEINE | ZAMBON SPA (IT) | 2011-01-19 | — | — | EP | disclosed |
| EP-1731143-A1 | Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure | NITTO DENKO CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-20060275354-A1 | Percutaneous absorption-type pharmaceutical preparation | NITTO DENKO CORPORATION | 2006-12-07 | — | — | US | disclosed |
| EP-1716850-A1 | Transdermal plaster | NITTO DENKO CORPORATION (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-20060234581-A1 | Adhesive preparation | NITTO DENKO CORPORATION (JP) | 2006-10-19 | — | — | US | disclosed |
| EP-0891782-B1 | Medical adhesive sheet and production thereof | NITTO DENKO CORP (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-20040025415-A1 | Decorative gel with in situ-formed crystals embedded therein, a process for making the decorative gel and items containing the gel | ZIMMERMAN BERNARD (US) | 2004-02-12 | — | — | US | disclosed |
| US-6652606-B1 | Decorative gel with in situ-formed crystals embedded therein, candles containing the gel, and a process for making the decorative gel and candles | UNGERER & COMPANY | 2003-11-25 | — | — | US | disclosed |
| US-6231883-B1 | SHEETS WITH SUPPORTS AND ADHESIVE LAYERS ON SUPPORTS | NITTO DENKO CORPORATION (JP) | 2001-05-15 | — | — | US | disclosed |
| EP-0891782-A2 | Medical adhesive sheet and production thereof | NITTO DENKO CORPORATION (JP) | 1999-01-20 | — | — | EP | disclosed |
| US-4032628-A | COSMETIC EMULSION COMPOSITIONS INCLUDING BLACK POLYMER EMULSIFIERS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283048-A1 | TEXTILE-SPARING ANTIPERSPIRANT SPRAYS WITH HYDROXYCARBOXYLIC ACIDS | HCAR1, HRH1, HRH4 | LMNA 3100/4885FAAH 12/4885ABCB1 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.